Methoxyacetic Acid

Methoxyacetic Acid

SCHEMBL17418261

COCC(=O)[O-].COCC[N+]1(C)CCOCC1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 2/20 0.48
APOBEC3A P31941 4/20 0.45
APOBEC3G Q9HC16 4/20 0.45
KDM4E B2RXH2 1/20 0.43
CTDSP1 Q9GZU7 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PABPC1 P11940 3/20 0.38
USP2 O75604 1/20 0.37
GAA P10253 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNA4 P43681 1/20 0.35
CNR1 P21554 2/20 0.33
CYP2D6 P10635 1/20 0.33
TERT O14746 5/20 0.33
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methoxyacetic Acid SCHEMBL17418718 0.88 CDC25A (0.44) CDC25AAPOBEC3AAPOBEC3GKDM4ECTDSP1
Methoxyacetic Acid SCHEMBL17418390 0.88 CDC25A (0.45) CDC25AAPOBEC3AAPOBEC3GCTDSP1L3MBTL1
Methoxyacetic Acid SCHEMBL17418583 0.85 KDM4E (0.61) CDC25AAPOBEC3AAPOBEC3GKDM4ECHRNB2
Methoxyacetic Acid SCHEMBL17418865 0.85 CDC25A (0.49) CDC25AAPOBEC3AAPOBEC3GCTDSP1L3MBTL1
Methoxyacetic Acid SCHEMBL17418535 0.84 PABPC1 (0.38) CDC25AAPOBEC3AAPOBEC3GCTDSP1L3MBTL1
Methoxyacetic Acid SCHEMBL17418385 0.84 KDM4E (0.65) CDC25AAPOBEC3AAPOBEC3GKDM4ECTDSP1
SCHEMBL1223460 0.83 KDM4E (0.59) CDC25AAPOBEC3AAPOBEC3GKDM4ECTDSP1
SCHEMBL17418580 0.82 APOBEC3A (0.41) CDC25AAPOBEC3AAPOBEC3GKDM4ECTDSP1
SCHEMBL17418368 0.82 APOBEC3A (0.41) CDC25AAPOBEC3AAPOBEC3GKDM4ECTDSP1
SCHEMBL17418651 0.82 APOBEC3A (0.41) CDC25AAPOBEC3AAPOBEC3GKDM4ECTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10087155-B2 Onium salt, liquid composition containing said onium salt and cellulose, and cellulose recovery method KOEI CHEMICAL COMPANY, LIMITED (JP) 2018-10-02 US disclosed
US-20160009669-A1 ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD KOEI CHEMICAL COMPANY, LIMITED (JP) 2016-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009669-A1 ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD CEL, CROCC, ALG1 CDC25A 2218/4885APOBEC3A 2939/4885APOBEC3G 2217/4885
US-10087155-B2 Onium salt, liquid composition containing said onium salt and cellulose, and cellulose recovery method CEL, CROCC, ALG1 CDC25A 2218/4885APOBEC3A 2939/4885APOBEC3G 2217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.